Related by context. All words. (Click for frequent words.) 71 clinical trials 63 clinical trial 59 Phase III trials 59 randomized clinical trials 57 Epidemiologic studies 57 randomized controlled clinical trials 56 placebo controlled trials 56 randomized trials 56 Phase IIIb study 56 Phase III clinical trials 55 multicenter clinical 55 midstage trials 55 phase IIb clinical 55 phase IIa 55 Preclinical studies 55 phase IIb trial 55 Inhaled insulin 55 Phase IIb trial 54 Phase IIb clinical trials 54 cetuximab Erbitux 54 GTC recombinant human 54 randomized multicenter trial 54 teriflunomide 54 olaparib 54 Phase 2b clinical trials 54 desmoteplase 54 randomized clinical 54 bioequivalence studies 54 Zolinza 54 YONDELIS 54 glatiramer acetate 54 midstage studies 54 trials RCTs 54 Statin drugs 54 phase IIa clinical 54 Phase 1b trial 53 topical formulations 53 sorafenib Nexavar 53 integrase inhibitor 53 quinacrine 53 Dabigatran 53 Sebivo 53 vaginal microbicide 53 Phase III clinical 53 etanercept Enbrel 53 Interferon alpha 53 ginkgo extract 53 budesonide foam 53 Afatinib 53 multicenter Phase II 53 PSN# [002] 53 multicenter study 53 Mipomersen 53 Raltegravir 53 Prodarsan 53 Abiraterone 53 lapatinib Tykerb 52 oral deforolimus 52 investigational protease inhibitor 52 cognitive enhancer 52 efficacy 52 Hydroxyurea 52 Combination therapy 52 SNT MC# 52 Ixempra 52 OvaRex ® MAb 52 cellulose sulfate 52 BRAF inhibitor 52 Phase IIb trials 52 Phase Ib clinical 52 histone deacetylase inhibitor 52 Certolizumab pegol 52 Phase IIa trial 52 retapamulin 52 tenofovir Viread 52 migraine prophylaxis 52 Etravirine 52 Aptivus 52 bevacizumab Avastin 52 clinical pharmacology studies 52 Vandetanib 52 multicenter clinical trials 52 Femara letrozole 52 Lisofylline 52 randomized controlled trial 52 preclinically 52 GSK# [002] 52 Everolimus 52 Vectibix panitumumab 52 Phase IIIb clinical 52 midstage clinical trials 52 placebo controlled studies 52 fluoroquinolone antibiotic 52 Phase IIa trials 52 bortezomib Velcade 52 canagliflozin 52 multicenter trials 52 cysteamine 52 DAPT 51 Zavesca R 51 pharmacokinetic studies 51 micafungin 51 darapladib 51 Civacir 51 placebo controlled clinical 51 albiglutide 51 randomized controlled 51 receptor inhibitor 51 caspofungin 51 RhuDex 51 CCR5 inhibitor 51 Zoraxel 51 tremelimumab 51 Phase 2b study 51 monotherapy 51 glucose lowering 51 treat menopausal symptoms 51 phase IIb study 51 Mosquirix 51 Desmoteplase 51 direct thrombin inhibitor 51 Safinamide 51 factor Xa inhibitor 51 Bendamustine 51 Dasatinib 51 insulin analogues 51 cardioprotective effects 51 randomized controlled trials 51 infliximab Remicade 51 phase Ib clinical 51 Certican 51 Aidsvax 51 Novartis Gleevec 51 Silodosin 51 Riluzole 51 Prodarsan ® 51 HAART regimens 51 Phase IIb clinical 51 eprotirome 51 ProSavin 51 Degarelix 51 GAMMAGARD LIQUID 51 HPTN 51 IMPROVE IT 51 systemic immunosuppressive drugs 51 DXL# 51 zidovudine AZT 51 EOquin TM 51 cannabinor 51 antiepileptic drug 51 streptokinase 51 Pertuzumab 51 Isentress raltegravir 51 tolevamer 51 preclinical studies 51 dasatinib Sprycel 51 eflornithine 51 phase IIb 51 antitumor effect 51 Cancidas 51 trastuzumab DM1 51 plasminogen activators 51 Phase IIb 51 MMP inhibitors 51 AERAS-#/Crucell Ad# 51 HIV protease inhibitors 51 liposomal amphotericin B 51 antithrombin 50 Phase #b/#a trial 50 sorafenib tablets 50 pharmacodynamic properties 50 udenafil 50 anticlotting drugs 50 Phase IIB 50 ancrod 50 quinolone antibiotic 50 adjunctively 50 dosage regimens 50 Glivec imatinib 50 Amrubicin 50 Factor VIIa 50 rimonabant Acomplia 50 Fodosine 50 erlotinib Tarceva ® 50 Rilutek 50 hypoxia activated prodrug 50 dabigatran etexilate 50 oral anticancer 50 microbicide trials 50 GeoVax vaccine 50 prospective observational 50 Phase 2b clinical 50 LY# [003] 50 VFEND 50 GAMMAGARD 50 Emselex 50 novel VDA molecule 50 TLK# 50 IIa trials 50 RoACTEMRA 50 active comparator 50 vitro experiments 50 Tocilizumab 50 tenofovir DF 50 PICSO ® 50 APTIVUS 50 gastrointestinal stromal tumors GIST 50 Phase #b/#a 50 relapsed ALL 50 Pemetrexed 50 ATryn ® 50 Spheramine 50 TREDAPTIVE 50 randomized controlled clinical 50 basal insulin analogue 50 sulphonylureas 50 EDEMA3 50 reslizumab 50 HGS# 50 GLPG# 50 ReoPro 50 investigational 50 Golimumab 50 Teriparatide 50 Phase 2b trial 50 sulodexide 50 MitoQ 50 human microdosing 50 Dalbavancin 50 orally dosed 50 pertuzumab 50 Fabry Disease 50 Instanyl 50 noscapine 50 pancreatic neuroendocrine tumors 50 AMN# [001] 50 anidulafungin 50 visilizumab 50 S/GSK# 50 immunomodulatory therapy 50 meropenem 50 XL# SAR# 50 Carvedilol 50 CBLC# 50 radiation sensitizer 50 Neulasta ® 50 Pharmacokinetic studies 50 riociguat 50 fidaxomicin Phase 3 50 Olmesartan 50 metastatic neuroendocrine tumors 50 immunotherapeutic vaccine 50 mTOR inhibitors 50 Phase IIIb 50 interferon beta 1b 50 anticancer therapy 50 Genasense ® 50 intranasal delivery 50 UCB Cimzia 50 optimal dosing 50 CCR5 antagonist 50 Apixaban 50 SGS# 50 Brilique 50 fosbretabulin 50 Anastrozole 50 pharmacokinetic characteristics 50 Arranon 50 Valproic acid 50 sodium valproate 50 ADAGIO study 50 double blinded placebo 50 antiplatelet drugs 50 Tamibarotene 50 oral FTY# 50 Lovastatin 50 Asentar 50 RhuDex ® 50 Qlaira 50 clinical 50 Phase Ib clinical trials 50 paromomycin 50 COMFORT II 49 Vorinostat 49 lipid lowering therapy 49 Trofex 49 Proellex TM 49 ezetimibe Zetia 49 Myocet 49 RSD# 49 bioequivalency 49 TYGACIL 49 SCH # 49 nebulized formoterol fumarate 49 valopicitabine 49 Azedra 49 Swine flu vaccines 49 Rivaroxaban 49 nucleoside analog 49 double blinded randomized 49 HBV vaccine 49 convenient dosing regimens 49 IL# PE#QQR 49 Entecavir 49 teratogenic effects 49 Tenofovir 49 polymerase inhibitor 49 blinded placebo controlled 49 Rasagiline 49 Herbal remedies 49 Alemtuzumab 49 Tetrabenazine 49 ZYVOX 49 TRILIPIX 49 tipranavir 49 ZD# [001] 49 PEGylated anti 49 clevidipine 49 Allovectin 7 49 depsipeptide 49 Advagraf 49 rosuvastatin 49 HepaSphere 49 intravenous formulations 49 rifalazil 49 calcitonin 49 IIa trial 49 ACZ# 49 IMA# 49 HCV protease inhibitors 49 Ophena TM 49 confirmatory clinical 49 HCV SPRINT 49 randomized multicenter Phase III 49 Cladribine 49 rosuvastatin Crestor 49 6R BH4 49 ZOLINZA 49 PD LID 49 Nivestim 49 injectable formulations 49 oral salmon calcitonin 49 clopidogrel Plavix 49 leukotriene receptor antagonist 49 Starlix 49 HuMax CD4 49 masitinib 49 AEG# 49 Antioxidant supplements 49 DiabeCell R 49 LC#m# 49 NSABP C 49 GRNCM1 49 recombinant interferon 49 Gilead Viread 49 laninamivir 49 blood thinner Xarelto 49 temsirolimus 49 Panzem 49 Phase IIA 49 liprotamase 49 perampanel 49 Rebif ® 49 Elvitegravir 49 Phase Ia 49 Clevudine 49 INCB# [001] 49 Vigabatrin 49 TELINTRA 49 AZILECT ® 49 VA# [002] 49 Phase #/#a clinical 49 aromatase inhibitor therapy 49 Gefitinib 49 Sutent sunitinib 49 eltrombopag 49 QLT# 49 Livial 49 TQT studies 49 Sorafenib Nexavar 49 Inhaled nitric oxide 49 Moxifloxacin 49 Roche Xeloda 49 tecarfarin 49 allogeneic HSCT 49 TAXUS TM 49 OHR/AVR# 49 PET tracers 49 Tanespimycin 49 Raptiva ® 49 pharmacodynamic profile 49 clavulanate 49 dose escalation clinical 49 anti leukemic 49 antibiotic minocycline 49 nonclinical studies 49 tolerability 49 hereditary deficiency 49 ixabepilone 49 LEUKINE 49 modulators SERMs 49 pain palliation 49 exemestane Aromasin 49 MAXY alpha 49 ALVESCO HFA 49 pemphigus vulgaris 49 vardenafil Levitra 49 ORMD 49 Phase 1b clinical 49 Previous studies 49 aripiprazole Abilify 49 rEV# 49 Amplimexon 49 Hepatocellular Carcinoma HCC 49 co trimoxazole 49 anti arrhythmic drug 49 Kidney transplants 49 Flu vaccines 49 cediranib 49 PULMICORT RESPULES 49 multicenter Phase III 49 KAPVAY ™ 49 luliconazole 49 ProLindac 49 multicenter randomized placebo controlled 49 zafirlukast 49 paricalcitol 49 Afinitor everolimus 49 beta interferons 49 EndoTAG 49 antiandrogen 49 Noxafil 49 Daclizumab 49 valdecoxib 49 iniparib 49 inhibitor RG# 49 statistically significant efficacy 49 Neupro R 49 docetaxel Taxotere ® 49 Observational studies 49 ONGLYZA ™ 49 PEP# [003] 49 tramiprosate Alzhemed TM 49 Viread Emtriva 49 macrolide antibiotics 49 tocilizumab 49 cMET 49 ToGA 49 Plicera 49 diabetic neuropathic pain 49 Randomized trials 49 DU #b 49 carvedilol 49 PrEP 49 MyVax 49 CDP# 49 treat enlarged prostates 49 Onconase 49 canakinumab 49 Lupuzor 49 CANCIDAS 49 pioglitazone HCl 49 raltegravir 48 Phase #b/#a clinical 48 Roflumilast 48 oral anticoagulants 48 Angiox R 48 catheter occlusion 48 Orally administered 48 PEARL SC 48 HCV RESPOND 2 48 Gammagard 48 bioabsorbable stent 48 Liprotamase 48 verteporfin 48 oral anticoagulant 48 Alinia 48 blood clot preventer 48 INSPIRE Trial Phase III 48 lipid lowering 48 cardio renal 48 Tykerb lapatinib 48 CYT# potent vascular disrupting 48 Subgroup analysis 48 BARACLUDE ® 48 Aryplase 48 non alcoholic steatohepatitis 48 omega interferon 48 Eculizumab 48 Zoledronic acid 48 TMC# [002] 48 MEK inhibitors 48 Ilaris 48 superficial bladder cancer 48 Anidulafungin 48 Factor Xa inhibitor 48 antithrombotic 48 Celtura 48 Drug eluting stents 48 Lisofylline LSF 48 oral bisphosphonates 48 Irinotecan 48 Antiviral medications 48 chemical entities NCEs 48 ganetespib 48 tribendimidine 48 echinocandin 48 Tekamlo 48 investigational drug 48 LEP ETU 48 preclinical efficacy 48 Phase 2a trial 48 glatiramer 48 Cloretazine 48 antiangiogenic agents 48 Adentri 48 entinostat 48 MenACWY 48 AVE# 48 thetreatment 48 Screening Trial 48 investigational therapies 48 RSD# oral 48 Zerit 48 IRESSA 48 iii GTx 48 Neuvenge 48 liposomal ciprofloxacin 48 Omiganan 48 Cabazitaxel 48 Ophena 48 rBChE 48 DIABECELL 48 randomized multicenter 48 Tindamax R 48 trastuzumab Herceptin 48 clevudine 48 intravenous cyclophosphamide 48 Hiberix 48 BYETTA exenatide injection 48 PecFent 48 Leukine 48 fluvastatin 48 afamelanotide 48 post menopausal osteoporosis 48 Aflibercept 48 Fingolimod 48 tibolone 48 CytoFabTM 48 Mirapexin 48 Phase III Clinical Trials 48 ZoMaxx 48 Circadin R 48 urine dipstick 48 Didanosine 48 overactive bladder OAB 48 CB2 selective receptor agonist 48 therapies ACTs 48 Aerosurf 48 pitavastatin 48 Phase Ib 48 Stimuvax R 48 Kaletra lopinavir ritonavir 48 AZILECT 48 Elocalcitol 48 Tyrima 48 NOXAFIL 48 Phase 2a clinical 48 Tofacitinib 48 radiotracers 48 ulimorelin 48 BrachySil 48 Plasmin 48 Newborn screening 48 STELARA ™ 48 indibulin 48 saquinavir 48 liver toxicity 48 ORENCIA R 48 registrational 48 cardiotoxic 48 dexpramipexole 48 TELCYTA 48 recombinant insulin 48 oral RSD# 48 Mimpara 48 ASPIRE HIGHER 48 Cogane 48 pharmacodynamics 48 SCENESSE R 48 ACV1 48 darunavir 48 CLARITY study 48 Tacrolimus 48 UPLYSO 48 tetrahydrobiopterin 48 RISPERDAL ® 48 Allovectin 7 ® 48 OvaRex R 48 trabectedin 48 bevacizumab Avastin ® 48 Tekturna HCT 48 fenretinide 48 Torisel 48 BioMatrix 48 griseofulvin 48 fumagillin nanoparticles 48 MYCAMINE 48 RhuDex R 48 Blinatumomab 48 Prostate Lung Colorectal 48 Filgrastim 48 CNTO 48 randomized placebo controlled 48 Laquinimod 48 incyclinide 48 protease inhibitor PI 48 pharmacokinetic parameters 48 multicentre study 48 Erlotinib 48 HQK 48 Fondaparinux 48 dosing regimens 48 Gatifloxacin 48 C#G 48 phase IIb III 48 HORIZONS AMI trial 48 rivaroxaban Xarelto 48 nucleotide analogue 48 tadalafil Cialis 48 PREOS 48 Allovectin 7 R 48 INOmax 48 Antidepressant medications 48 PROMUS Element Stent 48 Ceftobiprole 48 Gleevec resistant 48 Eltrombopag 48 aminolevulinic acid ALA 48 injectable antibiotic 48 TACI Ig 48 rFVIIa 48 PDE4 inhibitor 48 Xanafide 48 PROSTVAC ® 48 Navelbine ® 48 CRLX# 48 teriparatide 48 refractory prostate cancer 48 torezolid phosphate 48 Retacrit 48 pregabalin Lyrica 48 Arixtra 48 synthetic progestin 48 Phase IIa 48 Interferon beta 1b 48 Novartis Zometa 48 Topical treatments 48 Phase IIa clinical trials 48 RhuDex TM 48 Tekturna aliskiren 48 preclinical 48 Litx 48 flutamide 48 MIS# 48 SEPET TM 48 European Sepsis Trial 48 ustekinumab 48 multicenter randomized 48 INVEGA SUSTENNA 48 teduglutide 48 R lenalidomide 48 PEGPH# 48 Zavesca r 48 lenalidomide dexamethasone 48 Kenya Malawi Mozambique 48 AQ4N 48 JAK inhibitor 48 NovoMix 48 nucleoside reverse transcriptase inhibitor 48 antiplatelet therapies 48 oral antiviral 48 mertansine 48 Exemestane 48 ARCOXIA 48 treatment naive genotype 48 Nexavar sorafenib 48 elvitegravir 48 BAY #-# 48 Pivotal Clinical Trial 48 anti arrhythmic 48 secretin 48 axitinib 48 tetracycline antibiotic 48 Erbitux cetuximab 48 Epidemiological studies 48 ATryn ® GTC recombinant 48 SYMBICORT 48 EmbraceAC 48 non resectable metastatic 48 non nucleoside HCV 48 huperzine 48 bendamustine 48 CINTREDEKIN BESUDOTOX 48 systemic fungal infections 48 Phase III randomized controlled 48 antiandrogens 48 neuroprotective properties 48 interferon beta therapy 48 immunosuppressant drug 48 epigenetic therapies 48 Herbal medicines 48 thrombotic thrombocytopenic purpura TTP 48 eribulin mesylate 48 investigational antiplatelet agent 48 Cx# [002] 48 Subgroup analyzes 48 Relovair 48 Maraviroc 48 FluCide 48 VivaGel TM 48 vaccine Rotarix 48 Protease inhibitors 48 Paxil paroxetine 48 Commonly prescribed 48 interferon lozenges 48 ConclusionThis 48 dexamethasone Decadron 48 Plenaxis TM 48 plasma kallikrein inhibitor 48 raloxifene Evista 48 FOLOTYN ® 48 BioSTAR R 48 lumiliximab 48 nitazoxanide 48 levosimendan 48 antidiabetic 48 Alequel 48 basal bolus regimen 48 pill Xarelto 48 interferon therapy 48 plasma kallikrein 48 Calcitonin 48 ruxolitinib 48 bexarotene 48 galiximab 48 INVEGA ™ 48 symptomatic BPH 48 mesylate 48 PREVENAR 48 Researchers 48 galantamine 48 pegylated liposomal doxorubicin 48 REG1 48 ibandronate 48 orally bioavailable 48 Ushercell 48 dose escalation Phase 48 Phase IIa clinical 47 Phase III registrational 47 vicriviroc 47 adipiplon 47 Oracea TM 47 randomized blinded placebo 47 thiazolidinediones TZDs 47 number NCT# ClinicalTrials.gov 47 PCA3 assay 47 phase IIIb 47 pharmacokinetic interactions 47 PREDICTIVE 47 adalimumab Humira 47 cancer immunotherapies 47 gene therapy 47 sunitinib malate 47 novel oral anticoagulant 47 angiotensin receptor blockers ARBs 47 Personal CGM 47 Novolimus 47 Inhalation Solution 47 anti thrombotics 47 Lovenox enoxaparin 47 cellulose sulphate 47 VADT 47 Personalized Immunotherapy 47 Telintra 47 oral ridaforolimus 47 GnRH antagonist 47 EMPHASIS HF trial 47 rasagiline 47 dapsone 47 Voraxaze ™ 47 vitro studies 47 ENESTnd 47 evaluating REVLIMID 47 metreleptin 47 HIV HCV coinfected 47 Phase Ib II 47 diagnostic biomarker 47 BRIM3 47 stavudine d4T 47 Paromomycin 47 Tavocept 47 Omnitarg 47 neuraminidase inhibitor 47 Serdolect ® 47 Diamyd ® 47 nanopharmaceutical 47 Zometa zoledronic acid 47 nabilone 47 Sunitinib 47 cinacalcet 47 transdermal gel 47 Luveris 47 lenalidomide Revlimid R 47 MEK inhibitor 47 BioGard 47 Urine tests 47 ticagrelor Brilinta 47 NNRTIs 47 Azacitidine 47 Muraglitazar 47 Menerba 47 Foradil Aerolizer 47 gamma secretase inhibitors 47 PLX cells 47 cyclosporin 47 HCV NS5B polymerase 47 vivo preclinical 47 GLP toxicology studies 47 viral kinetics 47 blood clotting protein 47 calcineurin inhibitors 47 dirucotide MBP# 47 gefitinib Iressa 47 levocetirizine 47 Telmisartan 47 edifoligide 47 CaPre ™ 47 Oral corticosteroids 47 Eraxis 47 molecular entities NMEs 47 Carfilzomib 47 Antipsychotic medications 47 transdermal delivery 47 temozolomide 47 lomitapide 47 human papillomavirus vaccine Cervarix 47 urocortin 2 47 Methylnaltrexone 47 receptor blocker 47 AdreView 47 infantile colic 47 BioVant 47 Valcyte 47 ACOSOG Z# 47 DACH platinum 47 Aclidinium 47 nucleoside analogs 47 prospective randomized multicenter 47 NEUMUNE 47 maximally tolerated dose 47 forskolin 47 efavirenz Sustiva 47 rALLy clinical trial 47 isavuconazole 47 Cysteamine 47 vivo validation 47 Pafuramidine 47 vaginal microbicides 47 Urocidin 47 SARMs 47 CRMD# 47 Cimzia 47 rivaroxaban 47 Circadin 47 identifier NCT# 47 Bivalirudin 47 Alferon N Injection 47 Remicade infliximab 47 NO# [002] 47 Excellarate TM 47 Granulocyte Colony Stimulating Factor 47 BCR ABL inhibitor 47 Tarceva TM 47 Taxotere docetaxel 47 Kepivance 47 ELONVA 47 SPC# [001] 47 Temsirolimus 47 rNAPc2 47 tesofensine 47 leflunomide 47 dyskinesia PD LID 47 Onbrez Breezhaler 47 acting insulin analogs 47 BEZ# 47 Endeavor DES 47 Antiviral drugs 47 administered subcutaneously 47 Meta analyzes 47 GABITRIL 47 oral antidiabetic 47 antihypertensive drugs 47 relapsing multiple sclerosis 47 Desvenlafaxine 47 samalizumab 47 Trandolapril 47 Dabigatran etexilate 47 deferiprone 47 OncoVex 47 Merck KGaA Erbitux 47 Aurora kinase inhibitor 47 Tarvacin TM 47 Lispro 47 Oxiplex 47 Vivecon 47 Teysuno 47 CHAMPION PCI 47 paroxetine Paxil 47 Adult stem cells 47 progesterone gel 47 proteasome inhibitors 47 atorvastatin Lipitor 47 salmeterol fluticasone 47 dermaPACE TM 47 statin therapy 47 Paromomycin IM Injection 47 OncoVEX GM CSF 47 Aceon 47 ganaxolone 47 RE MODEL 47 Ovarian PLCO Cancer 47 Aliskiren 47 Velcade bortezomib 47 eluting stent 47 Atrasentan 47 Actimmune ® 47 Aromasin exemestane 47 Tekturna HCT ® 47 Faslodex 47 eptifibatide 47 SEBIVO 47 Sirolimus eluting Coronary Stent 47 StemEx 47 enalapril 47 antidiabetic drugs 47 enzyme inhibitor 47 Campath ® 47 EDEMA4 47 blood clot dissolver 47 oral bioavailability 47 FROVA 47 TKI therapy 47 Crizotinib 47 zoledronic acid 47 tacrolimus ointment 47 chemotherapeutic regimen 47 prospective randomized placebo 47 Androxal TM 47 Darunavir 47 PANVAC VF 47 ZYBRESTAT fosbretabulin 47 HIV integrase inhibitor 47 Corlux 47 Levetiracetam 47 nucleoside analogues 47 olopatadine 47 NeuroFlo 47 aldehyde dehydrogenase ALDH2 deficiency 47 Clioquinol 47 Losartan 47 trastuzumab Herceptin ® 47 dihydrochloride 47 Abbokinase 47 olanzapine Zyprexa 47 SIR Spheres 47 Arsenic trioxide 47 INGAP 47 direct renin inhibition 47 astemizole 47 APTIVUS r 47 antiretroviral therapy 47 pharmacodynamic effects 47 Phase III Clinical Trial 47 erlotinib Tarceva 47 transplanting stem cells 47 MAXALT 47 treating neuropathic pain 47 subcutaneous formulation 47 Seliciclib 47 Phase III 47 refractory CLL 47 ARIMIDEX 47 antitumor efficacy 47 biologic therapy 47 Edurant 47 mg RDEA# 47 Immunotherapeutic 47 alpha agonists